K KRYS

Krystal Biotech Inc

$312.57

-8.37% ($28.55)

Volume 1.17M

52W High $382.54

52W Low $130.50

Market Cap $10.06B

Next Earnings Report

Last Reported

Aug 3, 2026 Beat

Actual: $1.79 vs. Consensus: $1.70

Last 12 quarters

Q1 2026 May 11, 2026

1-Day: -0.82%

Q1 2026 May 4, 2026

1-Day: -0.83%

Q4 2025 Mar 2, 2026

1-Day: +1.93%

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q4'25	$107.1M	+17.5%	89.8%	41.5%	$51.4M
Q3'25	$97.8M	+16.7%	94.2%	42.3%	$79.4M
Q2'25	$96.0M	+36.7%	92.5%	40.9%	$38.3M
Q1'25	$88.2M	+94.9%	94.3%	41.0%	$35.7M
Q4'24	$91.1M	+116.3%	94.6%	45.4%	$45.5M
Q3'24	$83.8M	+879.9%	92.0%	26.8%	$27.2M
Q2'24	$70.3M	+10,000.0%	91.5%	12.2%	$15.6M
Q1'24	$45.3M	+7,661.6%	94.7%	-14.8%	$932,000

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q2 2026	Aug 3, 2026	$1.70	$1.86	$1.79	+5.29%	Missed
Q1 2026	May 11, 2026	$1.46	$1.68	$1.83	+25.34%	Beat
Q1 2026	May 4, 2026	$1.42	$1.63	$1.83	+28.87%	Beat
Q4 2025	Mar 2, 2026	$1.58	$1.82	$1.70	+7.59%	Missed
Q4 2025	Feb 17, 2026	$1.58	$1.85	$1.70	+7.59%	Missed
Q3 2025	Nov 3, 2025	$1.12	$1.13	$2.66	--	Beat
Q2 2025	Aug 4, 2025	$1.44	$1.21	$1.29	-10.42%	Beat
Q1 2025	May 6, 2025	$1.52	$1.01	$1.20	-21.05%	Beat
Q1 2025	May 5, 2025	$1.03	$0.92	$1.20	+16.14%	Beat
Q4 2024	Feb 24, 2025	$1.85	$2.05	$1.53	-17.39%	Missed
Q4 2024	Feb 19, 2025	$1.85	$2.04	$1.53	-17.39%	Missed
Q3 2024	Nov 4, 2024	$0.90	$0.85	$0.91	+1.11%	Beat